A. Ruth He

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

J. Marshall, Hongkun Wang, M. Pishvaian, 2021, Cancer medicine.

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.

J. W. Kim, M. Ikeda, Li‐Tzong Chen, 2022, NEJM evidence.

Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC

Huidong Shi, X. Qiu, Rui Mao, 2021, Hepatology.

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

M. Kudo, A. Santoro, A. El-Khoueiry, 2020, JAMA oncology.